ETS EMERGING THERAPY SOLUTIONS

Serial Number 88492279
Registration 5960197
700

Registration Progress

Application Filed
Jun 27, 2019
Under Examination
Approved for Publication
Oct 29, 2019
Published for Opposition
Oct 29, 2019
Registered
Jan 14, 2020

Attorney Assistance

Section 8 Declaration Due (Principal Register) (Based on registration date 20200114)
Due: Jan 14, 2026 17 days

Trademark Image

ETS EMERGING THERAPY SOLUTIONS

Basic Information

Serial Number
88492279
Registration Number
5960197
Filing Date
June 27, 2019
Registration Date
January 14, 2020
Published for Opposition
October 29, 2019
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 14, 2020
Registration
Registered
Classes
035 036 044

Rights Holder

Emerging Therapy Solutions, Inc.

03
Address
6301 Westwood Court
Edina, MN 55436

Ownership History

Emerging Therapy Solutions, Inc.

Original Applicant
03
Edina, MN

Emerging Therapy Solutions, Inc.

Owner at Publication
03
Edina, MN

Emerging Therapy Solutions, Inc.

Original Registrant
03
Edina, MN

Legal Representation

Attorney
Garrett M. Weber

USPTO Deadlines

Next Deadline
17 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20200114)
Due Date
January 14, 2026
Grace Period Ends
July 14, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

15 events
Date Code Type Description Documents
Jan 14, 2025 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Jan 14, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 29, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 29, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 9, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 23, 2019 ALIE A ASSIGNED TO LIE Loading...
Sep 18, 2019 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 18, 2019 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Sep 18, 2019 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Sep 18, 2019 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Sep 18, 2019 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Sep 17, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 10, 2019 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Jul 9, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 1, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 035
Business management and consulting services for the health care industry, namely, business management of cell, gene and other complex medical therapies for health plans, health insurers, self-funded plans, and reinsurers; business management and administration in the field of healthcare, namely, development, creation and implementation of health care provider networks; business administration of cell, gene and other complex therapy programs
First Use Anywhere: Jun 13, 2019
First Use in Commerce: Jun 13, 2019
Class 036
Financial consultation to healthcare providers, namely, providing assistance in obtaining reimbursement of health care expenses related to cell, gene and other complex therapies
First Use Anywhere: Jun 13, 2019
First Use in Commerce: Jun 13, 2019
Class 044
Consulting services in the field of medical care, namely, developing medical treatment policies related to cell, gene, and other complex therapies; medical information services related to cell, gene and other complex therapies
First Use Anywhere: Jun 13, 2019
First Use in Commerce: Jun 13, 2019

Additional Information

Design Mark
The mark consists of the letters "ETS" in large bold lettering, above the words "EMERGING THERAPY SOLUTIONS", in smaller lettering. To the left of the letters and words are two hexagons, one on top of the other, and slanted to the right. To the left of the slanted hexagons is a smaller hexagon, also slanted to the right.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
035 036 044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"EMERGING THERAPY SOLUTIONS"